Filing Details
- Accession Number:
- 0001181431-12-052226
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-09-27 18:43:27
- Reporting Period:
- 2012-09-25
- Filing Date:
- 2012-09-27
- Accepted Time:
- 2012-09-27 18:43:27
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1011835 | Medivation Inc. | MDVN | Pharmaceutical Preparations (2834) | 133863260 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1328448 | Daniel Adams | C/O Medivation, Inc. 525 Market St., 36Th Floor San Francisco CA 94105 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2012-09-25 | 5,000 | $6.97 | 5,000 | No | 4 | M | Direct | |
Common Stock | Disposition | 2012-09-25 | 5,000 | $55.00 | 0 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2012-09-27 | 23,038 | $6.97 | 23,038 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2012-09-27 | 60,000 | $9.38 | 83,038 | No | 4 | M | Direct | |
Common Stock | Disposition | 2012-09-27 | 83,038 | $55.73 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2012-09-25 | 5,000 | $0.00 | 5,000 | $6.97 |
Common Stock | Stock Option (Right to Buy) | Disposition | 2012-09-27 | 23,038 | $0.00 | 23,038 | $6.97 |
Common Stock | Stock Option (Right to Buy) | Disposition | 2012-09-27 | 60,000 | $0.00 | 60,000 | $9.38 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
23,038 | 2018-06-15 | No | 4 | M | Direct | |
0 | 2018-06-15 | No | 4 | M | Direct | |
0 | 2017-06-14 | No | 4 | M | Direct |
Footnotes
- Shares were sold pursuant to a 10b5-1 Plan.
- The shares were sold at prices ranging from $55.00 to $55.01. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- This option was previously reported but has been adjusted here to reflect the 2-for-1 stock split of the issuer's common stock that occurred on September 21, 2012.
- Fully Vested
- The shares were sold at prices ranging from $55.52 to $56.14. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.